Literature DB >> 29848733

Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.

Radka Obermannova1, Martina Redova-Lojova2, Petra Vychytilova-Faltejskova1,2, Peter Grell1, William C Cho3, Milana Sachlova1, Marek Svoboda1, Rostislav Vyzula1, Ondrej Slaby4,2.   

Abstract

BACKGROUND/AIM: In Western countries, most patients with gastric cancer (GC) present in advanced stages. Therefore, there is imminent clinical need for novel diagnostic and prognostic biomarkers. Deregulation of microRNAs has been reported as a frequent event in GC development in a number of studies. Our study validated the potential of microRNAs to serve as diagnostic and prognostic biomarkers in patients with GC from the Central European population.
MATERIALS AND METHODS: Using quantitative real-time polymerase chain reaction, expression levels of six microRNAs (miR-10b, -21, -93, -107, - 143, and -145) were examined in 67 tumor tissues and 67 paired adjacent gastric tissues, and correlated with clinicopathological features of GC patients.
RESULTS: Expression levels of miR-10b, miR-21, miR-93, and miR-107 were significantly higher in GC samples compared to non-tumor tissue. Furthermore, the expression levels of miR-10b, miR-143, and miR-145 positively correlated with advanced stages, and increased expression of miR-10b, miR-21 and miR-145 was significantly associated with worse prognosis of gastric cancer patients.
CONCLUSION: Our results indicate that selected tissue microRNAs have the potential to serve as relevant diagnostic and prognostic biomarkers of GC in a central European population. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Gastric cancer; diagnosis; microRNA; prognosis

Mesh:

Substances:

Year:  2018        PMID: 29848733     DOI: 10.21873/anticanres.12651

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Circular RNA circMAN2B2 promotes growth and migration of gastric cancer cells by down-regulation of miR-145.

Authors:  Bo Sun; Haiyuan Sun; Qunying Wang; Xinhong Wang; Jingzi Quan; Dongfang Dong; Yue Lun
Journal:  J Clin Lab Anal       Date:  2020-02-05       Impact factor: 2.352

2.  A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.

Authors:  Monika Wimmer; Roland Zauner; Michael Ablinger; Josefina Piñón-Hofbauer; Christina Guttmann-Gruber; Manuela Reisenberger; Thomas Lettner; Norbert Niklas; Johannes Proell; Mila Sajinovic; Paul De Souza; Stefan Hainzl; Thomas Kocher; Eva M Murauer; Johann W Bauer; Dirk Strunk; Julia Reichelt; Albert Sleiman Mellick; Verena Wally
Journal:  Cell Commun Signal       Date:  2020-04-10       Impact factor: 5.712

3.  Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.

Authors:  Shan-Shan Luo; Xi-Wen Liao; Xiao-Dong Zhu
Journal:  J Cancer       Date:  2019-10-17       Impact factor: 4.207

4.  Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis.

Authors:  Javad Behroozi; Shirin Shahbazi; Mohammad Reza Bakhtiarizadeh; Habibollah Mahmoodzadeh
Journal:  Int J Genomics       Date:  2020-12-18       Impact factor: 2.326

5.  MiR-450a-5p Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion and Promotes Apoptosis via Targeting CREB1 and Inhibiting AKT/GSK-3β Signaling Pathway.

Authors:  Ya-Jun Zhao; Jun Zhang; Yong-Cang Wang; Liang Wang; Xin-Yang He
Journal:  Front Oncol       Date:  2021-03-29       Impact factor: 6.244

6.  Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma.

Authors:  Huanqing Liu; Tingting Li; Chunsheng Dong; Jun Lyu
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

7.  Comprehensive evaluation of microRNA-10b in digestive system cancers reveals prognostic implication and signaling pathways associated with tumor progression.

Authors:  Yi Shen; Xiaolei Dai; Haibo Chen; Shuwei Zhai; Qiliang Peng; Shang Cai; Yaqun Zhu; Jian Huan; Yuntian Shen
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

Review 8.  The emerging role of miR-10 family in gastric cancer.

Authors:  Fang Liu; Yanfen Shi; Zuolong Liu; Ziyi Li; Wei Xu
Journal:  Cell Cycle       Date:  2021-07-07       Impact factor: 5.173

9.  The prognostic and diagnostic values of MicroRNA-10b in gastric cancer: A comprehensive study based on meta-analysis and TCGA database.

Authors:  Lina Mei; Zhouxiang Lu; Zhangguo Shen; Sumei Xu
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.